Return to Statistics Toolbox

Pathway mapping for Study ST001104

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample Type:Enriched SLC1G (1)
Sample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidase (1)
Sample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidase and O-glycosidase (1)
Sample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidase and O-glycosidase for comparison with seryl-leucine standard (2)
Sample Type:Enriched SLC1G after treatment with a2-3 neuraminidase (1)
Sample Type:Patient urine (1)
Sample Type:Seryl-leucine Standard (2)
Limit by pathway class:
Analysis:Combine data for all analyses?:     

  logo